Let's grab coffee at EANM 2023

Schedule a meeting or connect with me on LinkedIn to discuss your upcoming radiopharmaceutical study and how PSI can help.

image of Steven de hertefelt with teal circle border
De Hertefelt

Senior Director Business Development
Mobile: +32 477 90 80 05

Focused & specialized global radiopharmaceutical CRO

We specialize in pivotal Phase 2 and 3 oncology trials with a focus on radiopharmaceutical studies. Over the past 25 years, PSI has built a network of trusted radiopharmaceutical sites and has a regulatory team who can navigate the specific challenges for approvals.

Read our latest resource

Operationalizing Radiopharmaceutical Clinical Trials: Opportunities & Challenges

Success starts with understanding the risk factors that can impact your radiopharmaceutical trial from startup through the clinical phase.

strong corporate culture high employee tenure rate turnover rates lower than industry average
2,700 plus st
consistent delivery of reliable patient enrollment timelines with teal clock icon